News | March 10, 2015

Acute Myocardial Infarction Patient Treated with New Mechanical Thrombectomy Device

Aspire system removes thrombus occluding blood vessel in coronary arteries

Aspire, Control Medical, thrombectomy, atherectomy devices, cath lab

March 10, 2015 —George Adams, M.D., an interventional cardiologist with North Carolina Heart and Vascular, successfully treated a patient having an acute myocardial infarction (AMI) with the Aspire Mechanical Thrombectomy System.

The patient presented with chest pain, nausea and shortness of breath. An angiogram was performed and showed a long segment of thrombus occluding the ramus intermedius, a blood vessel in the coronary arteries. Adams used the Aspire Mechanical Thrombectomy device to remove the thrombus, and then he was able to angioplasty and stent the artery, relieving the patient from his symptoms.

"When a patient is having an AMI, removing the thrombus in the symptomatic artery is important," said Adams. "The Aspire device allows me to remove the thrombus quickly, helping to relieve the patients symptoms."

The Aspire System allows clinicians to instantly start, stop, increase, decrease, pulse or maintain thrombectomy force during the procedure. Aspire Mechanical Aspirators also aspirate up to 280ml, almost 10 times more than basic syringe systems, without multiple messy and time-consuming catheter connections, disconnections and re-connections.

The patented Aspire RX-LP6 Mechanical Thrombectomy System includes an Aspire Mechanical Aspirator (drive unit/pump) and a low-profile rapid-exchange (RX) thrombectomy catheter. Mechanical aspirators are also available alone and may be connected to any thrombectomy catheter the clinician chooses to use. Control Medical also manufactures Aspire Max Mechanical Thrombectomy Systems with larger over-the-wire (OTW) thrombectomy catheters for use in the peripheral vasculature.

For more information:

Related Content

News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...